La cadena de opciones muestra datos clave de las opciones de acciones de Dogwood Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Dogwood Therapeutics..

Dogwood Therapeutics (NASDAQ:DWTX) Bolsa, Cadena de Opciones

DOGWOOD THERAPEUTICS INC

Dogwood Therapeutics

Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACON

ALUR

ASST

AVBP

CNOB

DWTX

HSTM

IPHA

LGTY

MDXG

The Marygold Companies, Inc. Common Stock

MGLD

MULN

ONCO

PXLW

RMBI

TVGN

VINC

Explora los movimientos más destacados del pre-mercado, incluyendo el aumento del 23% en Logility y más sorpresas.

Acciones de Logility Supply Chain (LGTY) suben un 23%; 20 acciones que se mueven en el premercado de EE.UU.

ACTG

BTAI

CNTA

DALN

EVAX

FFBC

HYZN

LITM

MLYS

NVNI

PBBK

SEPN

STBX

TRUG

TWLO

Twilio sube un 18,5% tras superar expectativas de ingresos. Explora los movimientos clave del mercado previo de hoy.

Acciones de Twilio (TWLO) se disparan más de un 18%; 20 acciones que se mueven en el premercado de EE.UU.

ANAB

CCLD

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

HSDT

HUBC

LSTA

NEHC

NFLX

STFS

USEG

Netflix sorprende con un aumento en suscriptores y mejores pronósticos. Descubre también los mayores ganadores y perdedores del premercado.

Acciones de Netflix se disparan alrededor del 15%; 20 acciones que se están moviendo en el premercado de EE.UU.

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics Inc

Press Releases

Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance

Earnings

Dogwood Therapeutics Announces First Quarter 2025 Financial Results

Dogwood Therapeutics to Present at Sidoti Small-Cap Virtual Conference

Dogwood Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

Health Care

Dogwood Therapeutics Announces Enrollment of First Fifty Patients in Ongoing Halneuron® Phase 2b Trial

Dogwood Therapeutics Reports Second Quarter 2025 Financial Results

Dogwood Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference

Dogwood Therapeutics Secures Exclusive Worldwide, Royalty Free License to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients

Events

Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit

Dogwood Therapeutics to Participate at the Maxim Growth Summit 2025

Abpro Hldgs

Acurx Pharmaceuticals, Inc. - Common Stock

Acurx Pharmaceuticals

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Group

BioCardia

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

BioVie

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

FibroBiologics

Geovax Labs

Imunon

Immuron Limited - American Depositary Shares

Immuron

Longeveron

Marker Therapeutics

Neuphoria Therapeutics Inc. - Common Stock

Neuphoria Therapeutics

OSR Holdings

BiomX

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

Propanc Biopharma

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Soligenix

Sensei Biotherapeutics, Inc. - Common Stock

Sensei Biotherapeutics

HC Wainwright & Co.

Comments

Dogwood Therapeutics

Dogwood Therapeutics (DWTX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL